Rhythm Pharmaceuticals Stock
Rhythm Pharmaceuticals Stock
A loss of -2.780% shows a downward development for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals is currently one of the favorites of our community with 15 Buy predictions and no Sell predictions.
With a target price of 45 € there is a positive potential of 28.57% for Rhythm Pharmaceuticals compared to the current price of 35.0 €.
Our community identified positive and negative aspects for Rhythm Pharmaceuticals stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Rhythm Pharmaceuticals stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Rhythm Pharmaceuticals in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rhythm Pharmaceuticals vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Rhythm Pharmaceuticals | -2.780% | -5.914% | -4.372% | 125.806% | -17.840% | - | - |
Ardelyx Inc. | 1.320% | 0.305% | 18.209% | 119.818% | 25.121% | 26.877% | - |
Evolus Inc | 0.840% | 0.840% | 15.385% | 27.660% | 32.597% | 61.074% | - |
Salarius Pharmaceuticals Inc. | -6.190% | 3.684% | -7.075% | -65.439% | -29.009% | -98.470% | -99.993% |
Comments
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target lowered by analysts at Needham & Company LLC from $50.00 to $46.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
Show more
Ratings data for RYTM provided by MarketBeat